Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
Thuss Sanguansak, Prapapan Pitujaturont, Yosanan Yospaiboon, Suthasinee Sinawat, Tanapat Ratanapakorn, Chavakij Bhoomibunchoo Department of Ophthalmology, Faculty of Medicine, KKU Eye Center, Khon Kaen University, Khon Kaen, Thailand Objective: To study the macular sensitivity after half-dose vert...
Guardado en:
Autores principales: | Sanguansak T, Pitujaturont P, Yospaiboon Y, Sinawat S, Ratanapakorn T, Bhoomibunchoo C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c492592c3015478fa53674f0f38cdb8d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin Z, et al.
Publicado: (2014) -
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
por: Yu-Chen Hu, et al.
Publicado: (2021) -
Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon M, et al.
Publicado: (2013) -
Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
por: Dhirani NA, et al.
Publicado: (2017) -
Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita K, et al.
Publicado: (2012)